Skip to content
Parakho

SAKAR HEALTHCARE LIMITED

NSE SAKAR

Q1 FY27, unaudited

Revenue
₹72.97 Cr
Profit after tax
₹10.28 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations72.97+38.37%251.74
Other income1.54+291.95%2.29
Total income74.52+40.25%254.02
Employee benefit expense11.46+51.73%38.72
Finance costs1.67−22.07%7.86
Depreciation & amortisation6.54+17.41%23.56
Total expenses59.94+25.53%214.27
Profit before tax14.58+170.78%39.76
Tax expense4.30+502.07%9.27
Profit after tax10.28+120.17%30.48
Total comprehensive income10.26+120.86%30.38
Earnings per share
Earnings per share, basic₹4.62₹13.70
Earnings per share, diluted₹4.62₹13.70

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

FY26 from the company’s filing with NSE. Source

Earnings call

SAKAR HEALTHCARE LIMITED has not filed a concall transcript in the last 4 quarters.

Filings

0 shown · 0 published by the exchange

The exchange has published no filings for this company in the period Parakho holds.

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.